PD-L1 expression and survival in patients with locally advanced cervical cancer treated with chemoradiotherapy

被引：0
|
作者：
Enwere, E. [1 ]
Kornaga, E. [2 ]
Koulis, T. [3 ]
Dean, M. [2 ]
Phan, T. [3 ]
Ghatage, P. [4 ]
Magliocco, A. [5 ]
Lees-Miller, S. [6 ]
Doll, C. [3 ]
机构：
[1] Tom Baker Canc Clin, Pathol & Lab Med, Translat Lab, Funct Tissue Imaging Unit, Calgary, AB, Canada
[2] Tom Baker Canc Clin, Pathol & Lab Med, Translat Lab, Calgary, AB, Canada
[3] Univ Calgary, Oncol, Calgary, AB, Canada
[4] Univ Calgary, Gynecol Oncol, Calgary, AB, Canada
[5] Univ S Florida, H Lee Moffitt Canc Ctr, Anat Pathol, Tampa, FL 33682 USA
[6] Univ Calgary, Oncol Biochem & Mol Biol, Calgary, AB, Canada
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)30198-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
334
引用
收藏
页码：S65 / S65
页数：1
相关论文
共 50 条
  • [21] Risk assessment model for overall survival in patients with locally advanced cervical cancer treated with definitive concurrent chemoradiotherapy
    Shim, Seung-Hyuk
    Lee, Shin-Wha
    Park, Jeong-Yeol
    Kim, Young Seok
    Kim, Dae-Yeon
    Kim, Jong-Hyeok
    Kim, Yong-Man
    Kim, Young-Tak
    Nam, Joo-Hyun
    GYNECOLOGIC ONCOLOGY, 2013, 128 (01) : 54 - 59
  • [22] Risk assessment model for overall survival in patients with locally advanced cervical cancer treated with definitive concurrent chemoradiotherapy
    Shim, S.
    Kim, D.
    Lee, S.
    Park, J.
    Kim, J.
    Kim, Y.
    Kim, Y.
    Na, Y.
    Nam, J.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S49 - S50
  • [23] A nomogram for predicting survival of patients with locally advanced pancreatic cancer treated with chemoradiotherapy
    Choi, Seo Hee
    Park, Seung Woo
    Seong, Jinsil
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (02) : 340 - 346
  • [24] PD-1/PD-L1 Correlates With the Efficacy of the Treatment of Concurrent Chemoradiotherapy in Cervical Cancer
    Zhang, Hanqun
    Tan, Shisheng
    Fang, Chunju
    Zhang, Qi
    Cao, Xue
    Liu, Yuncong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [25] The comprehensive analysis of PD-L1 expression in cervical cancer
    Jiang, W.
    Yang, H.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 178 - 179
  • [26] A gene polymorphism in PD-L1 promoter region is not associated with PD-L1 expression and patients' survival in gastric cancer
    Wang, Weili
    Liao, Ping
    He, Yijing
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (10) : 1379 - 1381
  • [27] A gene polymorphism in PD-L1 promoter region is not associated with PD-L1 expression and patients’ survival in gastric cancer
    Weili Wang
    Ping Liao
    Yijing He
    Cancer Immunology, Immunotherapy, 2017, 66 : 1379 - 1381
  • [28] The expression of PD-L1 in patients with castrate prostate cancer treated with enzalutamide
    Richter, Igor
    Jirasek, Tomas
    Havlickova, Ivana
    Curcikova, Radmila
    Samal, Vladimir
    Dvorak, Josef
    Bartos, Jiri
    JOURNAL OF BUON, 2018, 23 (06): : 1796 - 1802
  • [29] Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy
    Jing Liu
    Guyu Tang
    Qin Zhou
    Weilu Kuang
    Radiation Oncology, 17
  • [30] Prognostic Value of Metabolic Change in Patients with Locally Advanced Cervical Cancer Treated with Chemoradiotherapy
    Li, C.
    Cai, R.
    Shi, H.
    Miao, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E701 - E701
12345